Herpes simplex virus: the importance of asymptomatic shedding

被引:106
作者
Koelle, DM
Wald, A
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[4] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
关键词
D O I
10.1093/jac/45.suppl_4.1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Herpes simplex virus (HSV) Is frequently shed after infection of the genital or perianal area. HSV shedding, as determined by culture, occurs on about 3% of days for immunocompetent women and men, and more for persons with HIV infection or if measured by polymerase chain reaction (PCR). Most horizontal and vertical transmission of HSV occurs during unrecognized or asymptomatic shedding, and the majority of HSV-2-infected persons are unaware of their infection. Many persons with 'asymptomatic' HSV-2 infection can learn to recognize genital signs and symptoms as recurrences of HSV-2 infection. However, some shedding episodes remain truly asymptomatic even after patient education. Antiviral therapy dramatically reduces asymptomatic shedding, and trials to evaluate its effect on HSV transmission are underway.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 53 条
[41]   Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons - A double-blind, placebo-controlled trial [J].
Schacker, T ;
Hu, HL ;
Koelle, DM ;
Zeh, J ;
Saltzman, R ;
Boon, R ;
Shaughnessy, M ;
Barnum, G ;
Corey, L .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (01) :21-+
[42]   Oral shedding of herpes simplex virus type 1: a review [J].
Scott, DA ;
Coulter, WA ;
Lamey, PJ .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1997, 26 (10) :441-447
[43]   ZOSTERIFORM SPREAD OF HERPES-SIMPLEX VIRUS AS A MODEL OF RECRUDESCENCE AND ITS USE TO INVESTIGATE THE ROLE OF IMMUNE CELLS IN PREVENTION OF RECURRENT DISEASE [J].
SIMMONS, A ;
NASH, AA .
JOURNAL OF VIROLOGY, 1984, 52 (03) :816-821
[44]   PATHOGENESIS OF HERPES-SIMPLEX LABIALIS - EXCRETION OF VIRUS IN THE ORAL CAVITY [J].
SPRUANCE, SL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (05) :675-679
[45]   Genital herpes in a primary care clinic - Demographic and sexual correlates of herpes simplex type 2 infections [J].
Wald, A ;
Koutsky, L ;
Ashley, RL ;
Corey, L .
SEXUALLY TRANSMITTED DISEASES, 1997, 24 (03) :149-155
[46]   New therapies and prevention strategies for genital herpes [J].
Wald, A .
CLINICAL INFECTIOUS DISEASES, 1999, 28 :S4-S13
[47]   Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir [J].
Wald, A ;
Zeh, J ;
Barnum, G ;
Davis, LG ;
Corey, L .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (01) :8-15
[48]   VIROLOGICAL CHARACTERISTICS OF SUBCLINICAL AND SYMPTOMATIC GENITAL HERPES INFECTIONS [J].
WALD, A ;
ZEH, J ;
SELKE, S ;
ASHLEY, RL ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (12) :770-775
[49]   Frequent genital herpes simplex virus 2 shedding in immunocompetent women - Effect of acyclovir treatment [J].
Wald, A ;
Corey, L ;
Cone, R ;
Hobson, A ;
Davis, G ;
Zeh, J .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :1092-1097
[50]  
WALD A, 1995, 35 INT C ANT AG CHEM, P199